Podcasts about healthtech

Meet Lindsay Friedman, a four-time healthcare startup founder on a mission to solve real-world problems in caregiving and long-term care. From https://carebloom.com/ a breakthrough monitoring platform that gives families peace of mind 24/7 to https://www.ltcarenav.com/ w comprehensive care planning solutions, Lindsay has spent her career connecting families with the resources they desperately need. In this episode, she shares her entrepreneurial journey, what drives her passion for healthcare innovation, and how her ventures are reimagining the way we care for our aging loved ones. #HealthcareInnovation #StartupStories #Caregiving #LongTermCare #Entrepreneurship #FamilyCare #HealthTech #FounderStories #CarebloomApp #SeniorCare #MedicalTech #PeaceOfMind #HealthcareStartup #SolveRealProblems #MedicalInnovationPinkCloud9 Media is Video Podcaster have interviewed 500+ CEOs, Authors, Speakers, Coaches,Executives, Business Leaders & Professionals & looking to promote more for your Visibility, Authority & Evergreen Content to my 100,000+ audience reach since 2020. Topic is always Business & your specialization the subtopic. Also booking Speakers for online events globally. Book your Business Episode Host:Book your 15-30 minute Episode SPECIAL here:https://calendly.com/pinkcloud9media/actual-livestream-recordingPodmatch discount here:https://www.joinpodmatch.com/pinkcloud9mediaGet to know our Complimentary Community w an Exclusive Benefits optionhttps://www.patreon.com/c/PinkCloud9MediaLinkedin here:https://www.linkedin.com/in/pinkcloud9/https://www.youtube.com/@PinkCloud9MediaLinktree here: https://linktr.ee/PinkCloud9

Pharma ads, biotech IPOs, $1M longevity programs, oh my!This month's Digital Health Download skews towards biotech, which is having a moment. Tune in to hear Halle and Michael cover the latest headlines.We cover:Why pharma ads are surging and the growing push for restrictions on D2C drug advertisingHims & Hers' $1.15B acquisition of Eucalyptus, its global expansion strategy, and the FDA crackdown on compounded GLP‑1 drugsThe return of biotech IPOs, with Eikon Therapeutics and Generate Biomedicines signaling investor interest in platform‑based drug discoveryVaccine makers scaling back research amid policy uncertainty, declining uptake, and tighter fundingTrumpRx's “most favored nation” drug pricing approach, and what one STAT analysis foundBryan Johnson's $1M per year “Immortals” longevity program—Show notes:Should drug companies be advertising to consumers? (The New York Times) Hims & Hers Enters $1.15 Billion Agreement to Acquire Eucalyptus (PharmExec.com)A sign biotech is back? Four drugmakers go public, raising nearly $1 billion in all (STAT)Vaccine Makers Curtail Research and Cut Jobs (The New York Times) TrumpRx claims to offer the lowest prices. But many drugs have cheaper generics (STAT)Bryan Johnson's Immortals: $1M to try longevity regimen (Axios) —"Halle Tecco wanted to see tech used for better medical services and getting people engaged in their own health. Now, she's written a book on how she went about it." - The WSJMassively Better Healthcare is out now!—Rock Health's annual CEO Summit is returning to the New York Stock Exchange on March 27th! Learn more and nominate a CEO to join this invite-only event here. —

How to Create Memorable Trade Show Experiences in Healthcare On this episode host Adam Turinas is joined by two of his colleagues from Health Launchpad, Design Lead Pepper Fee and Account Director Amy Hamilton. Both Amy and Pepper bring decades of experience in healthcare IT marketing and design to the table, having managed everything from massive trade show booths for global corporations to high impact activations for startups. They discuss why the traditional obsession with lead volume often misses the mark, and how to reframe events as tools for building and growing human relationships in an increasingly digital world. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Jessica from SomX chat through all the best news from this week with Christoph Ruedig from Albion VC and Celestin de Wergifosse from Signatur Bio.

MAHA News dives straight into the fire this week as RFK Jr.'s explosive appearance on Joe Rogan sets the tone for the conversation. The hosts break down shocking claims of autism fraud in Minnesota, ballooning from an expected $3 million to $400 million annually, and the staggering estimate of $100 billion lost each year to Medicare and Medicaid fraud. They also unpack RFK's promise of a federal definition for ultra-processed foods by April and the potential rollout of front-of-package red, yellow, and green labeling. From Casey Means' tense confirmation exchanges over vaccines and “settled science” to debates over pesticides, food dyes, and the GRAS system, this episode blends policy, public health, and real-world consumer responsibility. The show closes with a look at emerging health technologies including ultrasound-based tumor destruction and nerve repair polymers. It's fraud, food, freedom, and futuristic medicine, with a side of bacon.

February 27, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: YOU(th) Health Tech raises $4.5M to expand smartphone-based health screening platform detecting 50+ digital biomarkers in under two minutes UFC Gym partners with NexGen MD Scientific to launch in-gym longevity clinics offering GLP-1s, peptides, and hormone replacement therapy XENOM raises $15M seed funding to launch "Decathlon of Fitness" with 10 standardized events, debuting at Dallas Cowboys facility in June More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → insider@fitt.co

Send a textHaresh Patel is a Silicon Valley CEO turned HealthTech innovator who has spent his career solving complex systems across technology, finance, and human health.Born in India and raised in New Hampshire, Haresh earned his electrical engineering degree from the University of Notre Dame before beginning a 25 year journey in Silicon Valley. His leadership spanned semiconductor and technology companies including Texas Instruments, PMC Sierra, Agilent, and WJ Communications, before culminating in the founding of Mercatus. What began as a kitchen table startup grew into the global standard for private market investment technology, supporting over $1.5 trillion in assets under management before being acquired by State Street.Haresh's most profound breakthrough did not happen in a boardroom but in a healing room.For 55 years, he lived with unexplained health symptoms that twelve specialists could not diagnose. Refusing to accept that there were no answers, Haresh applied the same systems thinking and pattern recognition that powered his business success to his own body. By connecting the dots conventional medicine had missed, he uncovered the root causes behind his condition, an experience that fundamentally reshaped his life and purpose.Today, he is the founder of Diagnostic MD AI and a leading advocate for integrating conventional medicine with proven alternative approaches through patient-centric, AI-driven diagnostics. He believes the future of healthcare lies not in choosing between Eastern and Western medicine, but in intelligently combining their strengths to understand the whole system.His forthcoming book, The Ghost in My Body, chronicles this journey from medical dead ends to healing breakthroughs, offering both a deeply personal story and a vision for how healthcare can evolve.https://hareshpatel.ai/Use code FA FOR 40% OFF Athletic greens is a non-negotiable part of my daily routine. With 75 absorbable vitamins and minerals in just one scoop a day, I have increased my energy, improved my immune function and so much more. To get your own AG at 20% off go to www.athleticgreens.com/functionallyautoimmune Order now for a free vitamin D3/K2 supplement and 5 free travel packs!Support the show

What does it actually take to say yes in healthcare when the system is wired to say no? In this episode of The Disrupted Podcast, Scott takes you straight into the field — from a brand-new administrator in Marietta, Georgia who's already revolutionizing her building eight days in, to a 190-patient facility in Charleston where the real conversation isn't about hospice referrals, it's about whether you have the staff to back it up. Scott gets honest about the moments where healthcare organizations talk a big game but fold when it matters — refusing acute visits to non-panel patients, locking providers into rigid workflows, and hiring bodies instead of talent. He challenges all of it. And he does it with the kind of clarity that only comes from someone who's actually in the buildings, at the dinner tables, and on the phone doing the hard work every day. From a nurse who deserves a Tesla to a wristband that could change emergency response forever, this episode is packed with real stories, bold ideas, and a simple but radical belief: that getting to the yes isn't just good business — it's the whole point of healthcare. If you're a provider, administrator, nurse, or healthcare leader who's tired of the way things have always been done, this one's for you. www.YourHealth.Org

Welcome to Pulse: Amplify, where we sit down with the leaders and changemakers shaping the future of health. Jordi Piera Jiménez joins Pulse to unpack the foundations of digital health.Fresh from stepping down as Director of Digital Health Strategy at the Catalan Health Service, Jordi reflects on what most health systems are still getting wrong: interoperability that's more theatre than reality, AI built on poorly structured clinical data, and the dangerous confusion of digital transformation with IT procurement.We explore why public health systems should own their digital infrastructure, how procurement can be a powerful lever for change, and why clinicians must be better supported to understand that documentation is the core of modern healthcare.Jordi shares a bold vision for the next decade: true digital public infrastructure, genuine patient agency over data, and platform economies that drive innovation without vendor lock-in.A thoughtful, systems-level conversation about infrastructure, governance, ethics — and getting the foundations right.Connect with Jordi: LinkedInVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Episode 72 - Alison Gardiner is CEO of Born Digital Health and co-founder of Sleepstation, a digital insomnia program and one of the UK's earliest NHS-adopted digital therapeutics, used across the NHS in England since 2011.Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

In this episode of Medsider Radio, we sat down with Rick Bente, co-founder and CEO of Indomo.Indomo's flagship device, ClearPen, is an investigational at-home corticosteroid injection designed to treat inflammatory acne.Rick has over 20 years of experience as an engineer and operator across medtech and pharma, with leadership roles at Medtronic, Insulet, and YourBio, focused on drug delivery and combination products. He is an inventor on more than 50 patents and has generated over $150 million in investments.In this conversation, Rick discusses how Indomo translated an in-office dermatology procedure into at-home care, why usability had to be engineered rather than trained, how the company decided when to exit stealth mode, and how proof-based milestones shaped its fundraising.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Rick Bente.

The new ARC Hub for HealthTech, a multimillion-euro Government investment to drive regional development by accelerating the commercialisation of cutting-edge, patient-focused research, has been officially launched at University of Galway. Focused on developing solutions to improve chronic disease management, the aim of the ARC Hub for HealthTech is to fast-track high-potential technologies in areas such as smart implants, advanced wearable medical devices, novel sensors and AI and machine learning-driven modelling. Hosted by University of Galway, in partnership with Atlantic Technological University (ATU) and RCSI University of Medicine and Health Sciences, the initiative forms part of Research Ireland's flagship Accelerating Research to Commercialisation (ARC) programme. Twenty-three projects are currently in the ARC Hub for HealthTech after being selected for their strong potential to improve patient outcomes. The launch of the ARC Hub for HealthTech – under the theme of 'Regional Roots. Global Presence' – included a showcase of some of the current projects which are being fast-tracked to commercialisation, including advanced sensory detection devices to prevent falls in elderly people and intelligent devices to help control blood pressure. Minister for Further and Higher Education, Research, Innovation and Science, James Lawless, T.D., said: "The ARC Hub for HealthTech has the potential to deliver game-changing acceleration of research commercialisation that will directly benefit individuals and communities in the West and North-West and further afield. As it continues to ramp up its operations and establish partnerships, the ARC Hub's ambitions are clear and far-reaching. I look forward to seeing the Hub progress in its endeavours, outputs and impact over the coming years." Dr Diarmuid O'Brien, Chief Executive of Taighde Éireann-Research Ireland, said: "The ARC Hub programme is one of the most proactive, imaginative and potentially disruptive programmes ever delivered by Research Ireland. Bringing together our leading researchers, entrepreneurs, investors and industry to create an environment where our best research ideas can be translated from the lab to the market represents an inclusive and scalable model for creating companies of the future." Peter Power, Head of the European Commission Representation in Ireland, said: "The ARC Hub for Health Technology is an operation of strategic importance under the European Regional Development Fund programme for the Northern and Western region. It aligns with the objective of EU Cohesion policy to support thriving innovation ecosystems for all regions. Thanks to the ARC Hub for Health Technology research will be translated into marketable products, thereby boosting the competitiveness of both the Northern and Western region and European competitiveness.'' President of University of Galway, Professor David Burn, said: "Today we are announcing more than a research and innovation entity – the ARC Hub for HealthTech is a remarkable opportunity to create a global powerhouse for healthcare in the Northern and Western regions of Ireland. With our partners and regional collaboration, we are seizing the moment to push the commercial impact of research with new supports, at a faster pace, with the overarching aim of bringing new healthcare, treatments and therapies to patients." President of Atlantic Technological University, Professor Orla Flynn, said: "ATU is delighted to be involved in the ARC Hub for HealthTech, working with our partners to advance healthtech research and innovation. Through this collaboration, we are supporting the development of new technologies, strengthening research and creating clearer pathways for bringing scientific discovery into real-world healthcare solutions. I wish the team every success in these endeavours, and to thank the funders for their support." Professor Cathal Kelly, Vice Chancellor of RCSI, said: "Improving patient outcomes must always be at th...

  Today on Galway Talks with John Morley  9am-10am  County Hall blow up over Bord Bia boss results in several councillors refusing to voice votes   Nursing home sector warns of serious gaps in key supports  Online Unhealthy Food Marketing Appears Every Four Minutes for Irish Children 10am-11am   Ukraine marks four years since Russian invasion   University of Galway food bank forced to turn away hundreds of students each week   We hear about the work of The Galway Sick Kids Foundation  11am-12pm  New €34m research-led HealthTech hub launched   And live music in studio from Darragh O'Dea 

Finn Stevenson, co-founder and chief executive officer of Flok Health, discusses the slow pace of change and the strategic shortfalls of public health organisations, the real-world health impact of these challenges and why tech is one part of the solution needed. Flok Health is an AI-powered physiotherapy clinic that provides patients with virtual appointments to treat back pain. The platform fuses AI and human physiotherapists for personalised care without long waiting lists. 

When Eric Lefkofsky's wife was diagnosed with breast cancer, it exposed how little technology and data were shaping cancer care, pushing the serial entrepreneur to build a different model.Lefkofsky is the founder and CEO of Tempus, now a $10B publicy traded health tech company, and previously founded Groupon. At Tempus, he's building a tech-first company applying multimodal data and AI to make diagnostics smarter and treatment decisions more tailored, starting in oncology and expanding across disease areas.We cover:What Tempus does in plain EnglishWhy Tempus built its own lab, and how it became one of the largest sequencers of cancer patients in the U.S.The hard part: extracting usable clinical data from EHRs and scaling to thousands of hospital connections and hundreds of petabytes of dataHow AI changes the patient-physician relationship, and why patients will increasingly arrive highly informedWhat Eric would change at CMS and HHS to responsibly pay for AI—About our guest: Eric Lefkofsky is the founder and CEO at Tempus, a leader in artificial intelligence and precision medicine. He is the co-founder and General Partner of Lightbank, a private venture capital firm specializing in investments in technology companies. He is also the co-founder of Pathos AI, a clinical stage biotechnology company focused on re-engineering drug development; Groupon (NASDAQ: GRPN), a global e-commerce marketplace; Mediaocean, a leading provider of integrated media procurement technology; Echo Global Logistics (NASDAQ: ECHO), a technology-enabled transportation and logistics outsourcing firm; and InnerWorkings (NASDAQ: INWK), a global provider of managed print and promotional solutions.He co-chairs the Lefkofsky Family Foundation with his wife Liz to advance high-impact initiatives that enhance lives in the communities served. Lefkofsky also serves on the board of directors of The Art Institute of Chicago and Northwestern Medicine. He holds a bachelor's degree from the University of Michigan and a J.D. from the University of Michigan Law School.—

Orchestration – The Decision Layer of AI Growth On this episode host Adam Turinas is diving into the “decision layer” of AI: Orchestration. This is where AI moves beyond just observing behavior and starts shaping how your go-to-market pipeline actually responds. He'll walk through a realistic healthtech scenario involving a complex sale to a hospital system to show you how orchestration works in the real world. He'll discuss how AI helps you prioritize accounts based on patterns rather than intuition, routes leads with actual conditional logic, and designs responses that coordinate multiple personas without creating chaos. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Samuel Okwuada sold his first software company for hundreds of thousands of dollars at 17 while studying pharmacy in the UK. Today, he runs Remedial Health, a YCombinator-backed Nigerian Healthtech startup that has raised over 50 million dollars, employs 450 people, operates 100 vehicles across three Nigerian cities, and delivers 100 million medicines annually to thousands of pharmacies and hospitals across Africa. But the journey from bedroom coder to healthcare logistics pioneer was anything but straightforward.You'll hear how Samuel started Remedial Health as healthtech without the tech, literally taking WhatsApp orders and scrambling to fulfill them manually before building the actual platform. He reveals why he would never build this company again, not even in his wildest dreams, despite raising over 50 million dollars and achieving massive scale. The operational nightmares of running what feels like running a city, managing 450 people from motor boys to engineers, dealing with law enforcement extortion on every delivery route, watching a truck carrying 50 million naira worth of medicine flip over on terrible roads just an hour after celebrating a major government contract.Samuel breaks down the real cost of building in Nigeria, explaining why Remedial Health is actually two businesses in one because you cannot outsource pharmaceutical logistics in a country with no dedicated cold chain infrastructure. This conversation goes deep into founder mental health, with Samuel candidly sharing how he oscillates between feeling invincible and wanting to quit every single day, how he manages burnout by binge-watching entire Netflix series in one sitting every two weeks, and why he stopped celebrating wins too much so failures don't hit as hard. He reveals the leadership lesson that changed everything when he crashed and burned trying to do everything himself, learning to throw new hires into the deep end and stay out of their way.For aspiring founders, Samuel shares tactical advice on raising venture capital as an African founder, explaining why you need to solve locally relevant problems that have proven models in developed markets so investors can see the vision, why resilience means taking countless rejections without taking them personally, and how to increase your surface area for luck by putting yourself in positions where opportunities can find you. He discusses the myth that startup journeys get easier with scale, the truth being you just face different problems whether it's having enough money in the bank or dealing with regulatory raids on your warehouses.The interview includes rapid-fire insights on honesty as his non-negotiable value, doing good while making profit in healthcare, why he would choose fundraising over bootstrapping despite the trade-offs, his leadership style of staying out of the way, early mornings with coffee as his productivity hack, and why if Remedial Health hits a billion dollar valuation he would only take one month off because more than that and he probably wouldn't come back to the company.Whether you're a founder navigating the chaos of African tech, an investor trying to understand the operational realities of frontier markets, or someone curious about what it really takes to digitize a traditional industry in Nigeria, this conversation delivers unfiltered truth about building at scale in challenging environments. Samuel doesn't sugarcoat the pain, the setbacks, or the moments where quitting felt like the rational choice. But he also shows why stubborn builders who refuse to give up eventually figure it out, one impossible problem at a time.This episode is sponsored by ObiexHQ

Send a textHealthcare has long promised a digital revolution, yet many clinicians feel more burdened than empowered. With AI now accelerating at a rapid pace, can this moment finally deliver on that promise?Dr. Robert Wachter, author of A Giant Leap, joins host John Driscoll to discuss how AI is evolving clinical workflows and decision-making, why "better than human" is good enough in our overburdened system, and the leadership choices that will determine whether AI reduces burnout or deepens healthcare's existing failures.

South East Technological University (SETU) is coordinating AM-Heal, a two-year, €400,000 Erasmus+ partnership designed to strengthen Additive Manufacturing (AM) skills for healthcare and rehabilitation. Working with partners in Spain, Malta, and Ukraine, SETU is leading AM-Heal to develop and deliver a Level 9 Micro-Credential, which will build digital skills and professional competencies at the intersection of AM and rehabilitation. The programme will be delivered through a blended approach, combining online learning via a multilingual e-learning platform with hands-on training in partner facilities. A dedicated 3D printing training hub in Kyiv will also be established to strengthen local capacity and support skills development linked to rehabilitation and recovery. Through the Department of Engineering Technology at SETU's Cork Road Campus, the University will guide the consortium process to define and validate the shared micro-credential specifications in line with European micro-credential principles. Each partner higher-education institution will deliver the micro-credential locally and award it under its own academic regulations and quality assurance procedures, ensuring consistent content while supporting local certification pathways across the consortium. Announcing the project, Principal Investigator of AM-Heal at SETU, David Alarco, explained that AM-Heal will build expertise in design, materials and workflows, equipping learners with the knowledge required to apply AM effectively in rehabilitation contexts. The project will also produce open-access educational materials and research-informed policy recommendations to support safe and ethical adoption of AM in medical education and professional training. "AM-Heal aims to strengthen professional education at the intersection of additive manufacturing and healthcare. Through a shared micro-credential and practical training, we want to support cross-sector collaboration, build capability, and help accelerate the safe, effective use of AM in rehabilitation and clinical education," Mr Alarco said. "This project builds on SETU's additive manufacturing education capacity developed through the HCI-funded AMASE programme (2020–2025), in collaboration with SEAM and Design+ technological gateways. The existing 3D Lab in the Engineering, Technology and Research (ETRC) Centre at SETU's Cork Road Campus in Waterford supports applied learning and project work in advanced manufacturing," he added. The project consortium brings together SETU, PODOGLOBAL (ES), Associació Meraki Projectes de València (ES), Borys Grinchenko Kyiv Metropolitan University (UA), and the University of Malta (MT). For more information on the project, see AM-Heal. More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-tech-news If you'd like to be featured in an upcoming Podcast email us at Simon@IrishTechNews.ie now to discuss. Irish Tech News have a range of services available to help promote your business. Why not drop us a line at Info@IrishTechNews.ie now to find out more about how we can help you reach our audience. You can also find and follow us on Twitter, LinkedIn, Facebook, Instagram, TikTok and Snapchat.

Tänases Algorütmi episoodis räägime, kuidas startupkultuur, AI FOMO ja pidev enesearendamise surve mõjutavad tehnoloogiasektori inimeste vaimset ja füüsilist tervist. Arutame, kas inimesi põletab läbi keskkond või nad ise, miks 16-tunnised tööpäevad tunduvad normaalsed ning kuidas kirg oma töö vastu võib ohumärgid ära peita.Külas on HealthTech startup founder kogemusega arst ja koolitaja Ann Leen Mahhov.-----Jaga meile enda jaoks olulisimat mõtet episoodist meie Discord kanalis: https://discord.gg/8X5JTkDxccEpisoodi veavad Priit Liivak ja Erik JõgiAlgorütmi toetavadLHV https://www.lhv.ee/Nortal https://nortal.com/Codeborne https://codeborne.com/

Sunstone Health CEO Joshua Resnikoff joins Chris Lustrino to explain how Sunstone uses AI on healthcare claims data to proactively identify children with developmental delay—starting with epilepsy and autism—and help families reach the right specialists and diagnostics faster.They break down what claims data is, why the healthcare system is reactive by default, and how Sunstone's approach can compress what often takes years into roughly weeks by flagging high-need cases, coordinating advanced diagnostics, and delivering actionable next steps. Joshua also shares Sunstone's go-to-market strategy (positioned as an employer-paid benefit), why the pricing model is designed to reduce “point-solution bloat,” and how expansion could move across employers, TPAs, reinsurers, and large insurers. 00:00 Needle-in-a-haystack intro03:13 What Sunstone does (AI + claims data)05:32 Flagging patients vs. diagnosing07:21 Employer benefit + privacy model15:54 GTM + sales cycle reality17:57 Outcome-based pricing model20:16 Unit economics ($10k per case)22:11 Expansion paths + other diseases26:23 Fundraise use of proceeds28:03 Investor closing

The daughter of a hospital administrator, Amy Gleason never considered a career in the public sector – she went straight into healthcare. As an emergency room nurse, she started to see the dangers that unfold when healthcare providers don't have access to the information they need to treat patients. Those experiences drove her towards a tech career in the emerging electronic health records space before a very personal experience altered her professional path yet again.Amy's active and healthy 10-year old daughter began suffering unusual healthcare events, from rashes and headaches to broken bones. Eventually, she couldn't walk. It took more than a year from the start of these symptoms for doctors to diagnose her with a rare autoimmune disease. Even then, it was an accidental diagnosis from a dermatologist conducting a skin biopsy.Amy attributes the delayed diagnosis to siloed data, not unsimilar to the challenges she experienced as a nurse and was working to solve in the EHR space. It motivated her to co-found a company focused on helping patients with chronic diseases access their data to share it with the providers and family members helping to navigate complex care journeys.In 2015, Amy's work earned her an award from the White House for Champions of Change in Precision Medicine – her first foray into the public sector. By 2018, she entered civic service full time with a role at the United States Digital Service, which she describes as “DOGE 1.0.”In this episode of Healthcare is Hard, Amy talked to Keith Figlioli about the work she's doing now as Strategic Advisor to CMS and Administrator of the U.S. DOGE Service, where her main mission is modernizing technology across government agencies for the millions of people who rely on federal services every day. This ranges from modernizing FAFSA and the student loan process, to improving the Visa system ahead of the World Cup, and work on various critical healthcare systems. Some of the topics Amy and Keith discussed in this episode, include:Bold plans for a Digital Health Ecosystem. Launched in July 2025, CMS' Health Tech Ecosystem is a public-private partnership designed as a voluntary, fast-moving alternative to slow rulemaking. Rather than years of regulation, the program uses pledges, working groups, and short development cycles to put interoperability building blocks and real patient-facing use cases in place. The goal is to get usable capabilities into the market in months – not years – let the community iterate, and have baseline use cases live by March 31, 2026 with more advanced capabilities rolling out by July.Carrots and sticks before regulation. Recognizing the limitations of regulation, Amy talked about a new philosophy for incentivizing the market to change behaviors on its own first. “Carrots” include the rural health transformation fund and the recently introduced ACCESS model, a 10-year pilot that, for the first time, lets tech-enabled services bill Medicare directly. “Sticks” include stricter enforcement of information-blocking rules.Replacing the 1970s-era Medicare claims system. Amy discussed plans to replace Medicare's decades-old COBOL-based adjudication platform. While it's a stable platform, it can't support real-time processing, AI, or rapid change. To replace it, CMS is looking to commercial, off-the-shelf solutions that operate at scale so claims processing can be modernized, made real-time, and integrated with new interoperability rails. It's a concrete example of bringing modern engineering and product thinking to government technology.To hear Amy and Keith discuss these topics and more, listen to this episode of Healthcare is Hard: A Podcast for Insiders.

Can an algorithm truly care for a patient? As we move further into 2026, the healthcare industry is being flooded with AI tools promising to automate everything from charting to triage. But there's a massive problem: most of these tools are being built by engineers who have never spent a 12-hour shift on a med-surg floor. In this high-stakes conversation, Rebecca Love, RN, joins us to explain why the "Nursing Voice" is the most valuable asset in the 2026 tech landscape. We discuss the recent surge in ambient clinical scribes and the ethical "black boxes" of agentic AI—and why tech giants are destined to fail if they don't put nurses at the center of the development loop. This episode is a banger! Please like, follow and SUBSCRIBE!  What You'll Learn in This Episode: The Missing Link in Innovation: Why tech companies are struggling to achieve ROI because they lack the "frontline intuition" only a nurse provides. The 2026 AI Reality Check: A look at the current trends, from Google's Nurse Handoff tools to the 18% error rate recently found in some AI-generated discharge summaries. Ethics of the "Black Box": How nurses serve as the ultimate "Human-in-the-Loop" to prevent algorithmic bias and hallucinations from reaching the patient. Why Big Tech Can't "Do It Right" Alone: The specific clinical nuances—like reading a patient's non-verbal cues or navigating family dynamics—that cannot be coded into a Large Language Model (LLM). The Accountability Crisis: As AI begins drafting clinical work, who is legally responsible? Rebecca dives into the shifting liability landscape for RNs and NPs. More About Rebecca Love RN, BS, MSN, FIEL Rebecca Love, RN, BS, MSN, FIEL is an experienced nurse executive and first nurse featured on Ted.com, first nurse panel at SXSW. Rebecca is a regular contributor on the Forbes Business Council, has been featured in BBC, Fortune, Becker's, AXIOS, STAT, Forbes, Chief Healthcare Executive Magazine and ABC news and has co-authored two books: The Rebel Nurse Handbook and the The Nurses Guide to Innovation. Rebecca, was the first Director of Nurse Innovation & Entrepreneurship in the United States at Northeastern School of Nursing – the founding initiative in the Country designed to empower nurses as innovators and entrepreneurs, where she founded the Nurse Hackathon, the movement has led to transformational change in the Nursing Profession. In early 2019, Rebecca, along with a group of leading nurses in the world, founded and is President Emeritus of SONSIEL: The Society of Nurse Scientists, Innovators, Entrepreneurs & Leaders, a non-profit that quickly attained recognition by the United Nations as an Affiliate Member to the UN. Rebecca is an experienced Nurse Entrepreneur, founding HireNurses.com in 2013 which was acquired in 2018 by Ryalto, LTD UK, where she served as the Managing Director of US Markets, until it's acquisition in 2019. Rebecca served as the Chief Clinical Officer of IntelyCare, Inc. In 2023, Rebecca founded the Commission for Nurse Reimbursement- dedicated to solving the United States Nursing Crisis by creating a new economic model to reimburse for nursing services. Rebecca is passionate about empowering nurses and creating communities to help nurses innovate, create and collaborate to start businesses and inventions to transform healthcare. In 2024, Rebecca signed as the Co-Chair of the NursingIsSTEM Coalition. In addition, Rebecca sits as an advisory board member on several leading digital health startups and organizations, has co-authored 2 books, founded 3 companies, speaks internationally, and is dedicated and passionate about empowering nurses to be at the forefront of healthcare innovation and entrepreneurship. Connect with her on Linkedin: linkedin.com/in/rebeccalovenursing  Listen on Apple Podcasts – : The Gritty Nurse Podcast on Apple Apple Podcasts  https://podcasts.apple.com/ca/podcast/the-gritty-nurse/id1493290782 * Watch on YouTube –  https://www.youtube.com/@thegrittynursepodcast Stay Connected: Website: grittynurse.com Instagram: @grittynursepod TikTok: @thegrittynursepodcast Facebook: https://www.facebook.com/profile.php?id=100064212216482 X (Twitter): @GrittyNurse Collaborations & Inquiries: For sponsorship opportunities or to book Amie for speaking engagements, visit: grittynurse.com/contact Thank you to Hospital News for being a collaborative partner with the Gritty Nurse! www.hospitalnews.com   

This week on Pulse: Hot Topics, Louise and George tackle big shifts in medicines safety and the accelerating global AI race in healthcare.Australia moves toward a National Medicines RecordThe Federal Government announces reforms requiring medicines prescribed via online platforms to be uploaded to My Health Record — including clinical context. With medication-related harm accounting for around 250,000 hospital admissions annually, is this the safety infrastructure Australia has needed for decades?AI predicts 130 diseases from one night of sleepA new Nature Medicine study claims a sleep foundation model trained on 585,000 hours of data can predict future risk of more than 130 diseases. Breakthrough preventative medicine — or promising science with important caveats.China's AI healthcare surgeChina's Ant Group health chatbot reaches 30 million monthly users, embedded inside Alipay's super-app ecosystem. Meanwhile, China announces a $2–3 billion national AI healthcare strategy targeting population-scale deployment by 2030. Are we witnessing two divergent AI healthcare futures — cautious and regulated versus centralised and scaled?We are on tour!Charlotte Blease of #DrBot book fame and Louise are hitting the road together. Come see them in person and get your booked signed by Charlotte!Sydney: Tuesday 3rd March 6pm, Gleebooks, Glebe. Get tickets hereMelbourne: Tuesday 10th March 6.30pm, Mary Martin Bookshop, Southbank. Get tickets hereResourcesDr Sara Riggare's Checklist and Resources for Meaningful Engagement of Patients LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Send a textHow can patients and providers trust AI in healthcare if they don't understand how it works? In this clip from our episode "Making Healthcare Access Truly Borderless”, HealthBiz Podcast host David Williams speaks with Dr. Sarah Matt, author of The Borderless Healthcare Revolution, about why explainability and trust matter when AI is used in care delivery.Listen to the full episode here

Canadian HealthTech CEOs face a maze of privacy laws and AI governance gaps. This episode explores how cross-functional governance, clear decision rights, and bias-aware validation can turn structural complexity into more reliable AI adoption and better leadership decisions.For more information, visit https://www.augmentrstudio.com/healthtech-leadership-coaching Augmentr Studio City: Toronto Address: 339 1/2 Main Street Website: https://www.augmentrstudio.com/

In this episode of Medsider Radio, we sat down with Shaun Bagai, CEO of RenovoRx. The company is developing targeted oncology therapies and is currently commercializing RenovoCath, which is focused on pancreatic cancer. Before joining RenovoRx in 2014, Shaun spent over a decade in the cardiovascular space, including leading global market development at HeartFlow and helping establish the European renal denervation market at Ardian, which Medtronic acquired for approximately $1 billion. He began his career in clinical research and device sales at TransVascular and Medtronic. In this interview, Shaun discusses how testing markets with minimal infrastructure reveals what leads to commercial success, why clinical trial enrollment benefits from sales discipline, and what founders should understand about going public when traditional capital isn't available.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Shaun Bagai.

“This is such an exciting and fast-moving space.”Thanks for listening to Age Well with Dr Sophie Shotter!Find out more about Dr Sophie by heading to https://drsophieshotter.com/Follow Dr Sophie on Instagram… https://www.instagram.com/drsophieshotter/?hl=en…and Tik Tok https://www.tiktok.com/@drsophieshotter?lang=enThis podcast was produced by https://thepodcastpeople.co/Co-host: https://fionamattesini.co.uk/This show is sponsored by Primeadine – a clean, natural, and science-backed spermidine supplement – proven to up-regulate a range of health markers.Buy now at https://oxfordhealthspan.com/ and use the discount code DRSOPHIE for 20% off*****This show is sponsored by Microbz – harnessing good bacteria directly from UK soil which means more diversity and at least 15 strains of good bacteria in every shot.Buy now at https://microbz.co.uk/ and use the discount code SOPHIE20 for 20% off.The content in this podcast is for general information purposes only and is not meant to serve as medical advice or to replace or substitute advice given by, or consultation with, your doctor or any other healthcare professional. Please contact your healthcare provider if you have any questions or concerns about your health. Dr Sophie Shotter, her company and any employees or representatives are not liable for any claims arising out of or in connection with this podcast.Mentioned in this episode:This show is sponsored by Microbz – harnessing good bacteria directly from UK soil which means more diversity and at least 15 strains of good bacteria in every shot. Buy now at https://microbz.co.uk/ and use the discount code SOPHIE20 for 20% off.This show is sponsored by Primeadine – a clean, natural, and science-backed spermidine supplement – proven to up-regulate a range of health markers. Buy now at https://oxfordhealthspan.com/ and use the discount code DRSOPHIE for 20% off.

In this episode (recorded live), Halle Tecco speaks with Dr. Robert Wachter, Chair of Medicine at UCSF, about their concurrently released books on healthcare innovation and AI.They share thoughts on the dual challenge of innovation in healthcare and the role of AI, covering:Why past waves of tech failed to change healthcare and why AI may finally break throughHow AI is making a difference today in healthcareWhere AI-assisted diagnosis and prescribing could go next, and the risks of over-relying on humans “in the loop” How EHR vendors (like Epic) hold the "poll position" for AI implementation due to workflow integrationWhy innovators must become healthcare "anthropologists"; and clinicians must understand technology and AIPlus, a surprise guest from Prenuvo joins us to chime in. Order Halle's new book, Massively Better Healthcare hereOrder Bob's new book, A Giant Leap here—About our guest: Robert M. Wachter, MD is Professor and Chair of the Department of Medicine at the University of California, San Francisco (UCSF). Author of 300 articles and 6 books, he coined the term “hospitalist” in 1996 and is often considered the “father” of the hospitalist field, the fastest-growing medical specialty in U.S. history. He is a past president of the Society of Hospital Medicine, past chair of the American Board of Internal Medicine, a Master of the American College of Physicians, and an elected member of the National Academy of Medicine. Modern Healthcare magazine has ranked him among the 50 most influential physician-executives in the U.S. more than a dozen times; he was #1 on the list in 2015. His 2015 book, The Digital Doctor: Hope, Hype and Harm at the Dawn of Medicine's Computer Age, was a New York Times bestseller. His new book is A Giant Leap: How AI is Transforming Healthcare and What That Means for Our Future.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Surviving and Thriving in 2026 On this episode host Adam Turinas is joined by his two colleagues and fellow Health Launchpad principals, Mark Erwich and Matthew Piette, for a conversation about what it means to be a marketing leader in healthcare right now. They explore how the industry is moving from the traditional triple aim toward what we call the quintuple squeeze, where providers face intense pressure from regulatory changes, margin constraints, and severe staffing shortages. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Send a textHealthcare access is often treated as a technology problem, but the real barriers run much deeper. Geography, cost, culture, trust, and digital readiness all shape whether patients can actually get the care they need. Without addressing the system as a whole, even the most advanced tools risk leaving people behind.Sarah Matt, Author of The Borderless Healthcare Revolution, joins the HealthBiz Podcast to discuss what it truly takes to break down geographic barriers in healthcare, why access must be designed into systems from the start, and how technology can support care without replacing the human connection at its core. 

Welcome to Pulse: Amplify, where we sit down with the leaders and changemakers shaping the future of health. In this episode of Pulse Amplify, Louise and George sit down with Grahame Grieve, creator of FHIR and one of the most influential global figures in digital health.What followed was a wide-ranging conversation on community, leadership interoperability, and the impact of AI on healthcare. This episode moves beyond interoperability and into systems thinking, societal change, and the legitimacy of healthcare institutions in the age of AI.Connect with Grahame: LinkedInVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

What does it take to build a $100M healthcare company? Honestly, no one really knows — and the people who do don't tend to talk about it. But Steve Kraus and his team at Bessemer have actually studied it. They've analyzed hundreds of venture-backed healthtech companies and published the research. In this episode, I pull six lessons from their work and ask Steve to explain them.LinksSteve Kraus: https://www.bvp.com/team/steve-krausDr Mustafa Sultan: ⁠⁠⁠⁠https://www.musty.io⁠

In this episode of Medsider Radio, we sat down with Justin Zenanko, co-founder & CEO of SynerFuse.SynerFuse is developing the e-TLIF procedure, which combines spinal fusion with neuromodulation by placing leads directly at exposed nerves during surgery.A certified public accountant and serial entrepreneur, Justin previously served as CFO and senior vice president of corporate development at Recombinetics, where he led fundraising efforts totaling $68 million.In this interview, Justin discusses approaching FDA interactions as negotiations, validating procedures with off-the-shelf components before investing in custom devices, and structuring private raises through investment banks to preserve control while delaying institutional venture capital.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Justin Zenanko.

Physicians now face a world where search bars, chat apps, and large AI models are becoming many people's first stop for health questions, long before they enter a clinic.Former Google Chief Health Officer and national health IT leader Dr. Karen DeSalvo joins us to unpack what this shift means for clinicians, regulators, and patients, and why 15% of daily Google searches are questions no one has ever asked before.We cover:• Why consumer health search is becoming a powerful entry point into care• How Google built guardrails for safety, quality, and real-time monitoring of emerging risks• What the rise of GenAI “doctor in your pocket” tools could mean• The regulatory tensions ahead as states experiment with AI-driven medical decision support• How global demand, workforce strain, and new data sources (IoT, at-home diagnostics, wearables) are accelerating AI-supported primary care—About our guest: Dr. Karen DeSalvo is a health leader who has committed her career to improving health for everyone, everywhere. She was most recently Google's Chief Health Officer, where spearheaded a global team of health professionals dedicated to harnessing Google's technology and platforms to help everyone, everywhere live a longer, healthier life. Before Google, Dr. DeSalvo held significant roles in the U.S. government, including National Coordinator for Health Information Technology and acting Assistant Secretary for Health. She was also the Health Commissioner in New Orleans following Hurricane Katrina, where she led public health recovery efforts. Dr. DeSalvo currently sits on the Boards of Directors for Welltower and CityBlock Health and is a member of the Council of the National Academy of Medicine. —Pre-order Halle's new book, Massively Better Healthcare.—

Send us a textLynne Chou O'Keefe is the Founder and Managing Partner of Define Ventures, one of the largest early-stage health tech investment firms, with $800 million in assets under management.With deep experience across digital health, venture capital, and frontline healthcare systems, Lynne brings a clear-eyed view of why the industry is changing now and where AI can make a meaningful difference. She is widely recognized for her work backing companies that rethink access, outcomes, and patient experience, and is a trusted voice on how technology, ethics, and human judgment must come together to move healthcare forward.In this conversation, we discuss:Why healthcare still runs on fragmented systems and what that means for where AI can truly move the needle.How the shift from fee-for-service to value-based care changes incentives and pushes the system toward prevention over volume.Why patients now expect healthcare to work like transportation or food delivery, and how that expectation reshapes care delivery.The three phases of AI in healthcare, from administrative efficiency to clinical workflow support and, eventually, clinical decision-making.Where the ethical boundary sits today between AI-assisted care and AI-led decisions, especially when access to care is limited.Why the future of healthcare is hybrid by design, with AI augmenting clinicians rather than replacing human judgment.Resources:Subscribe to the AI & The Future of Work NewsletterConnect with Lynn on LinkedInAI fun fact articleOn how AI is fixing the biggest problem faced by doctors.

AI and Signal Intelligence On this episode host Adam Turinas dives into the critical first pillar of using AI to grow your pipeline: signal intelligence. He explains why interpreting patterns of behavior across entire accounts is far more valuable than simple lead scoring or tracking individual clicks. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Stop building "interesting" digital health apps that nobody buys. Bruce Hellman (uMotif) joins Jim and Eugene to reveal why "interesting" is the kiss of death for scaling in healthcare. We dive into the pivot from "crushing" civil service bureaucracy to finding "must-have" budgets in Global Pharma and Clinical Trial research. Explore the Mortar Theory of patient data and how to build for the "Citizen Scientist". Always Fun Mentions: Instagram Muscles: Eugene's quest for a 15-second handstand. Dubai Roots: Bruce as the first male born in Sharjah. Essex County: Britain's "finest" county. The Ski-Rep Era: 100+ days of career-building on the slopes. Chapters: 00:00 - Handstands & February Vibes 04:20 - Born in Sharjah 10:45 - The Bureaucracy Burn 17:15 - Meeting a Co-Founder at a Nursery Party 24:00 - Bricks & Mortar: The Data Theory 36:30 - The Pharma Pivot 49:15 - Follow the Money As always - we are meticulously unproduced.

In this episode of SaaS Fuel, host Jeff Mains sits down with Marlena Sarunac, co-founder of The Company Advice and marketing strategist for early-stage startups in complex, regulated industries like HealthTech, FinTech, and InsurTech. Marlena shares her "playbook nicely" approach—a proven framework that helps founders avoid reinventing the wheel while building go-to-market foundations that scale.The conversation explores why letting products "speak for themselves" is a dangerous myth in today's saturated market, how to translate technical complexity into clear messaging that resonates, and why focus beats trying to appeal to everyone. Marlena reveals common messaging traps (including ChatGPT-generated clichés like "turning chaos into clarity"), the critical difference between selling to buyers versus users, and how to navigate pivots without losing credibility.Key Takeaways4:43 - The Playbook Nicely Approach6:24 - Translating Complexity into Clarity11:04 - Why "Product Speaks for Itself" is Dangerous15:34 - Common Messaging Traps17:42 - Buyers vs. Users21:05 - Building Trust22:51 - Navigating Pivots24:53 - AI and the Human Spark28:46 - Visual Identity Matters More Than Ever32:06 - Brand Debt39:18 - SEO/AIO Strategy42:36 - Marketing as R&D, Not a Cost CenterTweetable Quotes"Startups don't have time to burn creating playbooks from scratch. Tap into what's been tried and true, then iterate as market signals evolve." - Marlena Sarunac"If I see another company say they 'turned chaos into clarity,' I'm going to scream. That's such a ChatGPT tell." - Marlena Sarunac"Features matter to users. Benefits matter to buyers. Don't confuse the two." - Marlena Sarunac"If you're making the right pivot, the audience you're pivoting away from won't care—they weren't showing traction anyway." - Marlena Sarunac"Treat AI like an early-career intern. It's great for automating tedious tasks, but you need humans in the loop to ensure differentiation."- Marlena Sarunac"Just like technical debt, brand debt accumulates when you take shortcuts. You'll pay for it eventually—and it'll be expensive." - Marlena Sarunac"Marketing isn't a cost center—it's the connective tissue between product and sales. Eliminating it is shortsighted." - Marlena SarunacSaaS Leadership Lessons1. Focus Beats BreadthTrying to sell to everyone dilutes your message and confuses the market. Get disciplined: focus on 1-3 buyer personas maximum. You can always expand later, but early-stage startups need clarity and traction, not broad appeal that resonates with no one.2. Separate Buyers from UsersYour buyers (decision-makers) and users (end-users) have different needs. Buyers care about business outcomes and ROI; users care about features and usability. Tailor your messaging accordingly: high-level benefits for buyers, detailed use cases and documentation for users.3. Build in Public, Iterate FastDon't wait for perfection. Put messaging out there when you're "half comfortable," gather market feedback, and iterate quickly. Use flexible systems (landing pages, modular websites) that allow rapid updates without massive overhauls....

Send us a textHow deep into AI do clinicians really need to go? In this clip from our episode "Making Healthcare Massively Better", CareTalk host John Driscoll speaks with Halle Tecco about why becoming AI-literate is the only way to build real guardrails as patients use tools like ChatGPT at scale.Listen to the full episode here

Episode 71 - Sara Roberts is a four-time HealthTech founder, strategic advisor and founder of Well Purposed, advising post–Series A HealthTech and longevity companies on ethical, sustainable scale and long-term impact.Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

We're back with our monthly rundown of the top headlines in health tech!Today, Halle and Steve sort through the biggest stories shaping the year ahead, from AI prescribing to lawsuits galore.We cover:AI prescribing (in Utah!)The FDA updated guidance on clinical decision support for AI in medicineThe lawsuit against Prenuvo after a missed stroke warning, and the broader debate over accountability in AI-assisted diagnosticsTexas' antitrust case against Epic - are they being anti-competitive?New evidence shows GLP-1 drugs lower employer healthcare costs by 9%Why healthcare hiring is slowing downHalle's book is now available! (Order now on Amazon)Show notes:Utah begins pilot of prescribing AI medication (Utah Department of Commerce)FDA issues guidance on wellness products, clinical decision support software (AHA)Man got $2,500 whole-body MRI that found no problems—then had massive stroke (Ars Technica)Texas sues Epic, accusing it of running a monopoly (Wisconsin Public Radio)Why cover GLP-1s? They'll lower employer healthcare costs, study says (Healthcare Dive)Hospitals' make-or-break year (Axios)

Right-Sized ABM with Brianna Miller On this episode host Adam Turinas welcomes Brianna Miller, the Director of Demand Generation at Cohere Health, to tackle one of my favorite subjects, Account-Based Marketing (ABM).They discuss why ABM does not have to be a massive investment in time and dollars. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen